Development of Novel Immunotherapy for Cancer
Not Applicable
Recruiting
- Conditions
- iquid and Solid Tumors
- Registration Number
- JPRN-UMIN000052314
- Lead Sponsor
- Ehime University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
Donors whose Hb values are less than 9.0 g/dL.
Study & Design
- Study Type
- Others,meta-analysis etc
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy and safety of gene-modified immune cells and antibodies.
- Secondary Outcome Measures
Name Time Method